Antiphospholipid antibodies in COVID-19: a meta-analysis and systematic review.

Published in: RMD open (2021)

aPLs were detected in nearly half of patients with COVID-19, and higher prevalence of aPL was found in severe disease. However, there was no association between aPL positivity and disease outcomes including thrombosis, invasive ventilation and mortality. However, further studies are required to identify the clinical and pathological role of aPL in COVID-19.

Keyphrases

systematic review
coronavirus disease
sars cov
risk factors
systemic lupus erythematosus
meta analyses
cardiovascular events
early onset
cardiovascular disease
metabolic syndrome
respiratory syndrome coronavirus
intensive care unit
skeletal muscle
drug induced
acute respiratory distress syndrome